Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bastien Jamet

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
JACC. Cardiovascular Imaging|April 13, 2023
<sup>18</sup>F-FDG-Based Radiomics and Machine Learning: Useful Help for Aortic Prosthetic Valve Infective Endocarditis Diagnosis?Thomas Godefroy, Gauthier Frécon, Antoine Asquier-Khati, et al.
Leukemia|August 7, 2025
Simultaneous whole-body multi-parametric 2-[<sup>18</sup>F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impactBastien Jamet, Cyrille Touzeau, Hatem Necib, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2020
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trialsBastien Jamet, Ludivine Morvan, Cristina Nanni, et al.
Circulation. Cardiovascular Imaging|June 30, 2022
18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular CardiomyopathyRoxane Tessier, Lara Marteau, Marc Vivien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM StudyClément Bailly, Thomas Carlier, Bastien Jamet, et al.
Ejhaem|July 18, 2022
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutationBaptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
Molecular Signature of <sup>18</sup>F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET StudyJean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, et al.
Blood|September 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trialFrançoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman, et al.
Seminars in Arthritis and Rheumatism|February 21, 2023
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosisVictor Genin, Jean-François Alexandra, Hubert de Boysson, et al.
Joint Bone Spine|May 10, 2026
French recommendations for the use of Imaging in Giant Cell ArteritisOlivier Espitia, Hubert de Boysson, Emmanuel Heron, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
JACC. Cardiovascular Imaging|April 13, 2023
<sup>18</sup>F-FDG-Based Radiomics and Machine Learning: Useful Help for Aortic Prosthetic Valve Infective Endocarditis Diagnosis?Thomas Godefroy, Gauthier Frécon, Antoine Asquier-Khati, et al.
Leukemia|August 7, 2025
Simultaneous whole-body multi-parametric 2-[<sup>18</sup>F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impactBastien Jamet, Cyrille Touzeau, Hatem Necib, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2020
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trialsBastien Jamet, Ludivine Morvan, Cristina Nanni, et al.
Circulation. Cardiovascular Imaging|June 30, 2022
18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular CardiomyopathyRoxane Tessier, Lara Marteau, Marc Vivien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM StudyClément Bailly, Thomas Carlier, Bastien Jamet, et al.
Ejhaem|July 18, 2022
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutationBaptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
Molecular Signature of <sup>18</sup>F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET StudyJean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, et al.
Blood|September 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trialFrançoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman, et al.
Seminars in Arthritis and Rheumatism|February 21, 2023
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosisVictor Genin, Jean-François Alexandra, Hubert de Boysson, et al.
Joint Bone Spine|May 10, 2026
French recommendations for the use of Imaging in Giant Cell ArteritisOlivier Espitia, Hubert de Boysson, Emmanuel Heron, et al.
Pageof 5